A Fortune 500 corporation, Brahmsit Pharma Inc has approved flagship of c-GMP, WHO and ISO 9000:2000 certified company and having footprint in 76 countries. Brahmsit Pharma Inc earned revenues of $30 billion in 2009, making it the 100th largest company in the United States and the 10th largest corporation by global pharmaceutical sales.
The company is publicly traded on the New York Stock Exchange and is a member of the S&P 500 stock index. Brahmsit Pharma Inc was one of the Nifty Fifty stocks that propelled the mid 20th century bull market.

-Developed by Sumit Salia